Halipa, Jaharia .
HRN: 18-69-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/04/2025
CEFUROXIME 1.5GM (VIAL)
12/04/2025
12/05/2025
IVT
1.5gms
Q8
LTCS
Checking Final Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes